Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia

Schizophrenia Research

Volumn 72, Issue 1, 2004, Pages 5-9

  Marder, Stephen R ^a   Fenton, Wayne ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Cognition; Functional capacity; Functional outcome; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT; NOOTROPIC AGENT;

COGNITION; COGNITIVE DEFECT; CONFERENCE PAPER; CONSENSUS; DRUG APPROVAL; DRUG INDUSTRY; DRUG TARGETING; FOOD AND DRUG ADMINISTRATION; FUNCTIONAL ASSESSMENT; GOVERNMENT; HUMAN; MEDICAL RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; COGNITION DISORDERS; CONSENSUS; HUMANS; INTERPROFESSIONAL RELATIONS; NEUROBIOLOGY; NEUROPHYSIOLOGY; NEUROPSYCHOLOGICAL TESTS; NEUROPSYCHOLOGY; PSYCHOPHARMACOLOGY; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 7544237332     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2004.09.010     Document Type: Conference Paper

References (20)

1. R. Axelrod, and W.D. Hamilton The evolution of cooperation Science 211 1981 1390 1396
2. R.M. Bilder, R.S. Goldman, D. Robinson, G. Reiter, L. Bell, J.A. Bates, E. Pappadopulos, D.F. Wilson, J.M. Alvir, M.G. Woerner, S. Geisler, J.M. Kane, and J.A. Lieberman Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates American Journal of Psychiatry 2000 157
3. J.S. Brekke, and J.D. Long Community-based psychosocial rehabilitation and prospective change in functional, clinical, and subjective experience variables in schizophrenia Schizophrenia Bulletin 26 2000 667 680
4. G. Bryson, and M.D. Bell Initial and final work performance in schizophrenia: cognitive and symptom predictors Journal of Nervous and Mental Disease 191 2003 87 92
5. W.T. Carpenter, and J.M. Gold Another view of therapy for cognition in schizophrenia Biological Psychiatry 51 2002 972 978
6. B. Cornblatt, M.F. Lenzenweger, R. Dworkin, and L. Erlenmeyer-Kimling Childhood attentional dysfunction predicts social deficits in unaffected adults at risk for schizophrenia British Journal of Psychiatry 161 1992 59 64
7. M.A. Geyer, and C.A. Tamminga Measurement and treatment research to improve cognition in schizophrenia: neuropharmacological aspects Psychopharmacology (Berl) 174 2004 1 2
8. M.F. Green What are the functional consequences of neurocognitive deficits in schizophrenia? American Journal of Psychiatry 153 1996 321 330
9. M.F. Green, R.S. Kern, D.L. Braff, and J. Mintz Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophrenia Bulletin 26 2000 119 136
10. H. Hafner, and W. an der Heiden Course and outcome of schizophrenia D.R. Weinberger Schizophrenia 2nd ed. 2003 Malden, Mass Blackwell 101 141
11. P.D. Harvey, E. Howanitz, M. Parrella, L. White, M. Davidson, R.C. Mohs, J. Hoblyn, and K.L. Davis Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites American Journal of Psychiatry 155 1998 1080 1086
12. P.D. Harvey, and R.S.E. Keefe Studies of the cognitive change in patients with schizophrenia following novel antipsychotic treatment American Journal of Psychiatry 158 2001 176 184
13. P.D. Harvey, M.F. Green, R.S.E. Keefe, and D.I. Velligan Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness Journal of Clinical Psychiatry 65 2004 361 372
14. J.D. Hegarty, R.J. Baldessarini, M. Tohen, C. Waternaux, and G. Oepen One hundred years of schizophrenia: a meta-analysis of the outcome literature American Journal of Psychiatry 151 1994 1409 1416
15. S.E. Hyman, and W.S. Fenton What are the right targets for psychopharmacology? Science 299 2003 350 351
16. S. Marwaha, and S. Johnson Schizophrenia and employment-a review Social Psychiatry and Psychiatric Epidemiology 39 2004 337 349
17. K.H. Nuechterlein, M.E. Dawson, M. Gitlin, J. Ventura, M.J. Goldstein, K.S. Snyder, C.M. Yee, and J. Mintz Developmental processes in schizophrenic disorders: longitudinal studies of vulnerability and stress Schizophrenia Bulletin 18 1992 387 425
18. J.S. Strauss, and W.T. Carpenter Characteristic symptoms and outcome in schizophrenia Archives of General Psychiatry 30 1974 117 120
19. D.I. Velligan, R.K. Mahurin, P.L. Diamond, B.C. Hazelton, S.L. Eckert, and A.L. Miller The functional significance of symptomatology and cognitive function in schizophrenia Schizophrenia Research 25 1997 21 31
20. D.I. Velligan, C. Bow-Thomas, R. Mahurin, A.L. Miller, and L.C. Halgunseth Do specific neurocognitive deficits predict specific domains of community function in schizophrenia? Journal of Nervous and Mental Disease 188 2000 518 524